Showing 1 of 1 recruiting trials for “cln7-disease”
A First-in-Human, Open-Label, Dose-Escalation Study to Evaluate the Safety and Tolerability of Gene Therapy With TTX-381 for the Ocular Manifestations Associated With Neuronal Ceroid Lipofuscinosis Type 2 (CLN2) Disease
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →